US-based Mayo Clinic researchers have applied artificial intelligence (AI) to existing electrocardiogram (EKG) test to develop a system which detects 'asymptomatic left ventricular dysfunction' (ALVD), a precursor to heart failure. "The accuracy of the AI/EKG test compares favourably with other common screening tests," researchers said. ALVD is treatable when identified, researchers added.